MedTrace Logo

Benefits of CTO-PCI in Selected Cases With HFrEF (CTOHFrEF)

NCT02570087 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2015-10-07

No results posted yet for this study

Summary

The investigators studied the effect of CTO-PCI on left ventricular function and clinical parameters in patients with HFrEF.

Conditions

  • Chronic Total Occlusion Vessel

Interventions

PROCEDURE

chronic total coronary occlusion percutaneous intervention

Percutaneous intervention of chronic total coronary occlusion with stent implantation

Sponsors & Collaborators

  • Hospital Clinic of Barcelona

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2014-08-31
Completion
2014-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02570087 on ClinicalTrials.gov